查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1933837

冠状动脉CT血管造影术市场（按产品类型、技术、应用和最终用户划分），全球预测（2026-2032）

Coronary Computed Tomography Angiography Equipment Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，冠状动脉 CT血管造影术市场价值将达到 18.5 亿美元，到 2026 年将成长至 20.4 亿美元，到 2032 年将达到 34.7 亿美元，复合年增长率为 9.38%。

关键市场统计数据
基准年 2025 18.5亿美元
预计年份：2026年 20.4亿美元
预测年份 2032 34.7亿美元
复合年增长率 (%) 9.38%

全面介绍结合硬体效能、软体智慧和临床应用趋势的冠状动脉CT血管造影术设备

冠状动脉CT血管造影术系统是现代心血管诊断的核心，它将先进的影像硬体与复杂的重建和视觉化软体相结合，实现了对冠状动脉疾病的非侵入性评估。临床上对高解析度、低剂量影像的需求日益增长，推动了对能够在不同患者解剖结构上提供一致影像质量，并能无缝整合到不断发展的数位化医院基础设施中的系统的需求。

技术创新、平台主导的供应商策略以及不断演进的临床路径如何共同重塑冠状动脉CT血管摄影系统的采购和实施？

冠状动脉CT血管造影术领域正经历着变革性的转变，这主要得益于技术创新、医疗模式的演进以及人们对诊断准确性日益增长的期望。这项变革的核心在于降低辐射曝射量和提高影像质量，而这主要透过改进检测器设计、迭代重建演算法和优化采集通讯协定来实现。此外，人工智慧和机器学习技术也日趋成熟，成为能够简化工作流程、自动测量并标记临床相关观察的实用工具，从而缩短诊断时间并减少操作者差异。

评估2025年美国关税对冠状动脉CT血管造影术供应链、采购惯例和製造商策略的多方面影响

美国关税于2025年生效，对冠状动脉CT血管造影术生态系统产生了多方面的影响，波及供应商的经济状况、采购行为和产品策略。进口零件和整机关税的提高挤压了利润空间，促使製造商和经销商重新评估其采购决策。为此，一些供应商加快了零件供应来源的多元化，寻求替代製造地，并尽可能优先考虑本地化生产，以保障生产连续性免受关税波动的影响。

基于细分市场的洞察揭示了产品、技术、应用和最终用户方面的差异如何影响采购决策和临床实施策略。

市场细分为分析冠状动脉CT血管造影术市场提供了一个视角，每个细分维度都有不同的商业性和临床意义。按产品类型划分，检验了CT扫描器、软体和工作站市场。在CT扫描仪方面，64排、128排和256/320排系统之间的差异会影响其在高通量心臟影像和一般诊断应用方面的适用性。软体细分则将重建功能和视觉化功能区分开来。重建技术，例如滤波反投影和迭代重建，直接影响影像杂讯和剂量最佳化；而视觉化技术，例如3D渲染和多平面重建，则影响影像解读效率和后续的临床决策。工作站分为整合式和独立式两种，整合式系统优先考虑在供应商生态系统内实现高效的工作流程，而独立式系统则在异构成像环境中提供柔软性。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和战略要务正在塑造技术采纳路径和供应商合作模式。

区域趋势将在塑造冠状动脉CT血管造影术系统的应用模式、供应商策略和供应链设计方面发挥关键作用。在美洲，需求主要由大规模综合医疗保健系统和成熟的门诊诊断行业驱动，这些机构专注于高吞吐量、先进的临床通讯协定和强大的服务网络。特定市场的报销政策、认证标准和集中采购结构会影响供应商合作模式和扩展服务协议的普及程度。

企业策略优先考虑平台扩充性、软体主导的差异化和卓越的服务质量，以确保临床信任和持久的商业性关係。

冠状动脉CT血管造影术领域的主要企业正围绕着几个策略要务进行整合：平台扩充性、软体差异化和完善的服务生态系统。许多供应商正在投资开发可扩展的架构，以实现增量升级，使客户无需更换整个系统即可添加高级心臟应用或增强的重建演算法。这种方法既能减少对临床团队的影响，保护采购投资，又能透过软体订阅和生命週期服务创造持续的收入来源。

为製造商、供应商和采购团队提供实用建议，以加快采用速度、保护现有资产价值并降低供应链和海关风险。

产业领导者应采取果断措施，使其产品蓝图、商业模式和营运能力与心血管影像领域不断变化的需求保持一致。製造商应优先考虑模组化设计和软体升级方案相结合的方式，既能保持现有系统的价值，又能实现临床功能的逐步增强，而无需完全更换硬体。这将为客户提供顺畅的升级路径，并支援与软体和分析相关的持续收入模式。

透明的调查方法结合了专家访谈、设备功能映射、监管审查和供应链跟踪，检验商业性和临床结论。

本分析的调查方法结合了定性研究（包括领域专家访谈）、全面的设备和软体功能映射，以及透过对监管资讯和专利申请资讯进行三角验证的技术声明检验。主要资料收集包括对临床负责人、生物医学工程师和采购负责人进行结构化访谈，以了解实际决策标准和挑战。此外，也辅以厂商巡迴推广和匿名客户回馈，以了解服务绩效和升级实务。

本文概述了决定长期成功的策略挑战，这些挑战涵盖技术、供应链韧性和以买家为中心的服务模式。

总之，冠状动脉CT血管造影术正处于转折点，这主要得益于成像硬体、重建演算法以及软体驱动的临床工作流程等方面的技术进步。这些发展正在改变临床医生评估冠状动脉和血管疾病的方式，并推动采购标准的转变，使其更加重视临床表现、生命週期柔软性和可预测的服务支援之间的平衡。关税相关的波动凸显了价值链韧性和在地化策略的重要性，同时也促使供应商更加关注软体升级和模组化，将其作为低成本增加差异化价值的手段。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 冠状动脉CT血管造影术设备市场（依产品类型划分）

  • CT扫描仪
    • 128 片
    • 256/320 片
    • 64片
  • 软体
    • 重建
    • 视觉化
  • 工作站
    • 融合的
    • 独立版

9. 按技术分類的冠状动脉CT血管造影术设备市场

  • 128 片
  • 256/320 片
  • 64 行切片

第十章 冠状动脉CT血管造影术设备市场（依应用领域划分）

  • 心臟影像
  • 血管影像

第十一章 冠状动脉CT血管造影术设备市场（依最终用户划分）

  • 诊断中心
  • 医院
  • 研究所

第十二章 冠状动脉CT血管造影术设备市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 冠状动脉CT血管造影术设备市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国冠状动脉CT血管造影术设备市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国冠状动脉CT血管造影术市场

第十六章：中国冠状动脉CT血管造影术设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Analogic Corporation
  • Canon Medical Systems Corporation
  • Carestream Health
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • NeuroLogica Corporation
  • Neusoft Medical Systems Co., Ltd.
  • Planmed Oy
  • Samsung Electronics Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Toshiba
  • United Imaging Healthcare Co., Ltd.
Product Code: MRR-C36616F69972

The Coronary Computed Tomography Angiography Equipment Market was valued at USD 1.85 billion in 2025 and is projected to grow to USD 2.04 billion in 2026, with a CAGR of 9.38%, reaching USD 3.47 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.85 billion
Estimated Year [2026] USD 2.04 billion
Forecast Year [2032] USD 3.47 billion
CAGR (%) 9.38%

Comprehensive introduction to coronary CT angiography equipment that frames the convergence of hardware performance, software intelligence, and clinical adoption dynamics

Coronary computed tomography angiography equipment occupies a pivotal position in modern cardiovascular diagnostics, blending advanced imaging hardware with sophisticated reconstruction and visualization software to enable noninvasive assessment of coronary artery disease. Increasing clinical demand for high-resolution, low-dose imaging has intensified the need for systems that deliver consistent image quality across a variety of patient anatomies while integrating seamlessly into evolving digital hospital infrastructures.

Against this backdrop, stakeholders from manufacturers to hospital purchasing teams face a more complex landscape than ever before. Technology differentiation now extends beyond raw detector counts to encompass algorithmic reconstruction, workflow automation, and software-enabled clinical decision support. Consequently, decisions about procurement and deployment hinge on a combination of clinical performance, total cost of ownership, interoperability, and the vendor's ability to support lifecycle upgrades.

The introduction outlines the technical and operational contours that define contemporary coronary CT angiography equipment, explaining how hardware choices, software capabilities, and end-user needs converge to shape purchasing strategies and clinical adoption patterns. It also frames the subsequent analysis by highlighting critical inflection points in clinical practice and supply chain dynamics that have immediate implications for manufacturers, health systems, and research institutions.

How technological innovation, platform-driven vendor strategies, and evolving clinical pathways are jointly redefining procurement and adoption of coronary CT angiography systems

The coronary CT angiography landscape is undergoing transformative shifts driven by technological innovation, evolving care models, and heightened expectations for diagnostic precision. At the heart of this transformation is a broad move toward enhanced image quality with reduced radiation exposure, achieved through advances in detector design, iterative reconstruction algorithms, and optimized acquisition protocols. Moreover, artificial intelligence and machine learning are maturing into practical tools that streamline workflow, automate measurements, and flag clinically relevant findings, thereby reducing time-to-diagnosis and variability between operators.

Simultaneously, vendor strategies are increasingly platform-centric, favoring modular architectures and software-upgrade pathways that extend the useful life of installed systems. This shift is reinforced by intensified competition among manufacturers to offer integrated solutions that combine imaging hardware, post-processing workstations, and cloud-enabled analytics. In parallel, clinical practice is moving toward earlier, noninvasive assessment of coronary disease and greater use of CT-derived functional metrics, which elevates software performance and post-processing capabilities as decision-making differentiators.

These changes interrelate with broader healthcare trends: outpatient diagnostic centers are expanding cardiovascular imaging services; value-based care programs emphasize diagnostic efficiency and risk stratification; and regulatory environments demand transparent validation of AI-driven tools. Taken together, these forces are reshaping procurement criteria, driving a premium on adaptability, and creating opportunities for manufacturers and service providers that can demonstrate reproducible clinical value and cost-effective lifecycle management.

Evaluating the multifaceted effects of United States tariffs implemented in 2025 on supply chains, procurement practices, and manufacturer strategies in coronary CT angiography

The introduction of United States tariffs in 2025 has had a multifaceted impact on the coronary CT angiography equipment ecosystem, touching supplier economics, procurement behavior, and product strategies. Increased duties on imported components and finished systems have pressured margins and prompted both manufacturers and distributors to re-evaluate sourcing decisions. In response, several vendors accelerated diversification of their component supply bases, sought alternate manufacturing footprints, and prioritized localization where feasible to shield production continuity from tariff volatility.

Hospitals and diagnostic centers reacted by intensifying total cost-of-ownership analysis; capital planners placed greater emphasis on service contracts, spare parts logistics, and predictable lifecycle expenses to offset near-term price variability. Meanwhile, procurement teams extended lead time planning and increased scrutiny of maintenance terms to ensure uninterrupted clinical operations. For smaller equipment buyers and outpatient centers, financing and leasing arrangements gained appeal as mechanisms to preserve cash flow while maintaining access to advanced imaging capabilities.

At the product level, vendors re-prioritized modular upgrades and software-led differentiation as lower-tariff pathways to add value without incurring the full cost of hardware imports. In parallel, strategic partnerships with regional manufacturers and a renewed focus on after-sales service networks mitigated some tariff-driven disruptions. Regulatory and reimbursement environments further influenced these dynamics, as payers and health systems weighed cost pressures against the demonstrable clinical advantages of advanced CT angiography technologies. Together, these responses have established new operational norms in procurement, supply chain resilience, and vendor-client collaboration.

Segmentation-driven insights revealing how product, technology, application, and end-user distinctions shape procurement decisions and clinical deployment strategies

Segmentation provides a prism through which the coronary CT angiography market can be analyzed, and each dimension yields distinct commercial and clinical implications. By product type, the market is examined across CT scanners, software, and workstations; within CT scanners, differentiation across 64-slice, 128-slice, and 256/320-slice systems determines suitability for high-throughput cardiac imaging versus more general-purpose diagnostic roles. Software segmentation separates reconstruction and visualization capabilities, where reconstruction methods such as filtered back projection and iterative reconstruction directly affect image noise and dose optimization, and visualization techniques like 3D rendering and multi-planar reconstruction influence interpretative efficiency and downstream clinical decision-making. Workstations are categorized as integrated or stand-alone, with integrated options favoring streamlined workflow within a vendor ecosystem while stand-alone workstations offer flexibility for heterogeneous imaging environments.

Looking through the technology lens, the market is studied across 64-slice, 128-slice, and 256/320-slice platforms, a breakdown that reflects both hardware capability and clinical intent; higher slice-count systems typically support advanced cardiac protocols and wider coverage per rotation. Application-based segmentation separates cardiac imaging from vascular imaging, underscoring divergent clinical workflows, contrast protocols, and post-processing needs. Finally, end users are identified as diagnostic centers, hospitals, and research institutes, each with distinct procurement cycles, utilization patterns, and priorities for service and training. Diagnostic centers often prioritize throughput and cost-effectiveness, hospitals emphasize integrated enterprise IT and regulatory compliance, and research institutes value modularity and high-performance configurations for investigative protocols.

Analyzing these segmentation layers in concert reveals where incremental innovation yields the greatest clinical and commercial advantage, and it highlights the decision criteria that different buyer types apply when evaluating product bundles and long-term support commitments.

Regional dynamics and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption pathways and vendor engagement models

Regional dynamics play a pivotal role in shaping adoption patterns, vendor strategies, and supply chain design for coronary CT angiography equipment. In the Americas, demand is driven by large integrated health systems and a mature outpatient diagnostics sector that emphasizes throughput, advanced clinical protocols, and robust service networks. Reimbursement policy, accreditation standards, and centralized procurement in certain markets influence vendor engagement models and the prevalence of extended service agreements.

Across Europe, the Middle East and Africa, heterogeneity defines market behavior: Western European markets often seek cutting-edge performance combined with stringent regulatory compliance and energy efficiency, whereas certain Middle Eastern and African markets emphasize rapid deployment and scalable service solutions to expand access to advanced imaging. Regional purchasing consortia and public health initiatives influence procurement cadence and vendor selection, while diverse regulatory pathways require targeted registration and validation strategies.

In the Asia-Pacific region, growth is supported by expanding hospital infrastructure, investments in domestic manufacturing capacity, and an increasing focus on preventive cardiology. Local regulatory evolution and variability in clinical practice encourage vendors to offer flexible financing, training programs, and regionally adapted service models. Cross-region supply chain strategies, tariff impacts, and partnerships with local distributors shape how quickly new technologies are introduced and scaled. Taken together, these regional nuances determine where investment in sales, service, and localized R&D will yield the highest strategic returns.

Corporate strategies that prioritize platform extensibility, software-driven differentiation, and service excellence to secure clinical trust and durable commercial relationships

Leading companies in the coronary CT angiography space are consolidating around a few strategic imperatives: platform extensibility, software-driven differentiation, and comprehensive service ecosystems. Many vendors are investing in scalable architectures that allow incremental upgrades, enabling customers to add advanced cardiac applications or enhanced reconstruction algorithms without replacing entire systems. This approach reduces disruption for clinical teams and protects procurement investments, while creating ongoing revenue streams through software subscriptions and lifecycle services.

A second trend centers on software and analytics. Companies are integrating AI-assisted tools for automated vessel analysis, plaque characterization, and workflow prioritization, which enhances clinical efficiency and helps demonstrate value to payers and system administrators. Partnerships with third-party software providers and acquisitions aimed at accelerating AI capabilities have become common strategic levers.

Service excellence remains a competitive differentiator. Manufacturers that can guarantee rapid field service, remote diagnostic support, and predictable parts availability retain stronger relationships with high-utilization clinical sites. Pricing models that blend capital, consumables, and service into transparent packages resonate with both hospitals and diagnostic centers. Finally, an emphasis on regulatory compliance and clinical validation underpins commercial credibility; companies that invest in peer-reviewed studies and robust post-market surveillance position themselves as trusted partners to health systems seeking long-term collaboration.

Actionable recommendations for manufacturers, providers, and procurement teams to accelerate adoption, protect installed-base value, and mitigate supply chain and tariff risks

Industry leaders should take decisive steps to align product roadmaps, commercial models, and operational capabilities with the evolving demands of cardiovascular imaging. Manufacturers ought to prioritize modular designs coupled with software-upgrade pathways that preserve installed-base value and enable incremental clinical enhancements without requiring full hardware replacement. By doing so, they can offer lower-friction upgrade paths for customers and create recurring revenue models tied to software and analytics.

Procurement teams and health system leaders should shift toward procurement frameworks that explicitly account for lifecycle service, interoperability, and clinical workflow integration. Evaluations should emphasize demonstrable improvements in diagnostic accuracy and throughput, as well as vendor commitments to training and remote support. Meanwhile, software vendors and analytics providers should invest in clinically validated algorithms and transparent performance reporting to accelerate acceptance among radiologists and cardiologists.

From a supply chain perspective, diversification of component sources, selective localization, and robust contingency planning are essential to mitigate tariff and geopolitical risks. Companies should also explore creative financing solutions, such as outcome-linked agreements or subscription models, to align vendor incentives with clinical performance. Finally, cross-sector collaboration among manufacturers, payers, and clinical leaders can drive standardized protocols and evidence generation that unlock broader adoption and optimize patient pathways.

Transparent research methodology combining primary expert interviews, device feature mapping, regulatory review, and supply chain tracing to validate commercial and clinical conclusions

The research methodology underpinning this analysis combined primary qualitative engagement with subject matter experts, comprehensive device and software feature mapping, and triangulation of regulatory and patent filings to validate technical claims. Primary data collection included structured interviews with clinical leaders, biomedical engineers, and procurement professionals to capture real-world decision criteria and pain points. These interviews were complemented by vendor briefings and anonymized customer feedback to understand service performance and upgrade practices.

Technical assessment involved systematic review of product specifications, reconstruction methods, and post-processing capabilities, with particular attention to how different hardware configurations support cardiac and vascular imaging protocols. Regulatory documentation and clinical literature were examined to evaluate validation evidence for advanced reconstruction techniques and AI-enabled tools. Supply chain analysis traced component sourcing, manufacturing footprints, and the operational effects of recent trade policy changes to assess resilience and potential vulnerabilities.

Insights were synthesized using a cross-validation approach that reconciled stakeholder perspectives with technical evidence and observed commercial behaviors. The methodology emphasized transparency in assumptions, reproducibility of technical comparisons, and a focus on operationally relevant metrics such as uptime, upgrade pathways, and training commitments rather than speculative market sizing.

Concise conclusion summarizing strategic imperatives across technology, supply chain resilience, and buyer-focused service models that will determine long-term success

In summary, coronary computed tomography angiography equipment is at an inflection point driven by technological advances in imaging hardware, reconstruction algorithms, and software-enabled clinical workflows. These developments are changing how clinicians evaluate coronary and vascular disease, and they are reshaping procurement criteria toward solutions that balance clinical performance, lifecycle flexibility, and predictable service support. Tariff-related disruptions have reinforced the importance of supply chain resilience and localized strategies, while also accelerating vendor emphasis on software upgrades and modularity as lower-cost pathways to add differentiated value.

Segment-level distinctions across product type, technology, application, and end-user inform targeted strategies for both vendors and buyers; understanding these nuances is essential to making informed procurement choices and to designing product roadmaps that address specific clinical needs. Regional differences further underscore the necessity of tailored commercial approaches that reflect regulatory complexity, reimbursement patterns, and infrastructure maturity. Ultimately, stakeholders who prioritize interoperability, validated software performance, and robust service models will be best positioned to deliver reliable clinical outcomes and to capture long-term value in a rapidly evolving environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Computed Tomography Angiography Equipment Market, by Product Type

  • 8.1. CT Scanner
    • 8.1.1. 128-Slice
    • 8.1.2. 256/320-Slice
    • 8.1.3. 64-Slice
  • 8.2. Software
    • 8.2.1. Reconstruction
    • 8.2.2. Visualization
  • 8.3. Workstation
    • 8.3.1. Integrated
    • 8.3.2. Stand Alone

9. Coronary Computed Tomography Angiography Equipment Market, by Technology

  • 9.1. 128-Slice
  • 9.2. 256/320-Slice
  • 9.3. 64-Slice

10. Coronary Computed Tomography Angiography Equipment Market, by Application

  • 10.1. Cardiac Imaging
  • 10.2. Vascular Imaging

11. Coronary Computed Tomography Angiography Equipment Market, by End User

  • 11.1. Diagnostic Centers
  • 11.2. Hospitals
  • 11.3. Research Institutes

12. Coronary Computed Tomography Angiography Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Coronary Computed Tomography Angiography Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Coronary Computed Tomography Angiography Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Coronary Computed Tomography Angiography Equipment Market

16. China Coronary Computed Tomography Angiography Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Analogic Corporation
  • 17.6. Canon Medical Systems Corporation
  • 17.7. Carestream Health
  • 17.8. Fujifilm Holdings Corporation
  • 17.9. GE HealthCare Technologies Inc.
  • 17.10. Hitachi, Ltd.
  • 17.11. Hologic, Inc.
  • 17.12. Koninklijke Philips N.V.
  • 17.13. NeuroLogica Corporation
  • 17.14. Neusoft Medical Systems Co., Ltd.
  • 17.15. Planmed Oy
  • 17.16. Samsung Electronics Co., Ltd.
  • 17.17. Shimadzu Corporation
  • 17.18. Siemens Healthineers AG
  • 17.19. Toshiba
  • 17.20. United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 128-SLICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 128-SLICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 128-SLICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 256/320-SLICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 256/320-SLICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 256/320-SLICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 64-SLICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 64-SLICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 64-SLICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY VISUALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY VISUALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY VISUALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY STAND ALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY STAND ALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY STAND ALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 128-SLICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 128-SLICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 128-SLICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 256/320-SLICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 256/320-SLICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 256/320-SLICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 64-SLICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 64-SLICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY 64-SLICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIAC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIAC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CARDIAC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GCC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 140. GCC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 142. GCC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. GCC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. GCC CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. G7 CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 164. G7 CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 165. G7 CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 166. G7 CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. G7 CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NATO CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 172. NATO CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 174. NATO CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. NATO CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. NATO CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY CT SCANNER, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY WORKSTATION, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)